bf/NYSE:GKOS_icon.jpeg

COM:GLAUKOS

Glaukos

  • Stock

Last Close

141.44

21/11 16:56

Market Cap

6.05B

Beta: -

Volume Today

38.47K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Medical Devices
  • website

    www.glaukos.com/
  • ipo date

    Jun 25, 2015

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. ...Show More

peer of

competitor of